CDC-Authored Genomics and Precision Health Publications Database
Last data update: Nov 04, 2024. (Total: 6390 publications)
| Query Trace: Kalman LV[original query] |
|---|
| DPYD genotyping recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium
Pratt VM , Cavallari LH , Fulmer ML , Gaedigk A , Hachad H , Ji Y , Kalman LV , Ly RC , Moyer AM , Scott SA , Turner AJ , van Schaik RHN , Whirl-Carrillo M , Weck KE . J Mol Diagn 2024 |
| Characterization of reference materials for DPYD: A GeT-RM collaborative project
Gaedigk A , Turner AJ , Moyer AM , Zubiaur P , Boone EC , Wang WY , Broeckel U , Kalman LV . J Mol Diagn 2024 |
| CYP3A4 and CYP3A5 genotyping recommendations: A joint consensus recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase
Pratt VM , Cavallari LH , Fulmer ML , Gaedigk A , Hachad H , Ji Y , Kalman LV , Ly RC , Moyer AM , Scott SA , van Schaik RHN , Whirl-Carrillo M , Weck KE . J Mol Diagn 2023 25 (9) 619-629 |
| Characterization of reference materials for CYP3A4 and CYP3A5: A genetic testing reference material coordination program collaborative project
Gaedigk A , Boone EC , Turner AJ , van Schaik RHN , Chernova D , Wang WY , Broeckel U , Granfield CA , Hodge JC , Ly RC , Lynnes TC , Mitchell MW , Moyer AM , Oliva J , Kalman LV . J Mol Diagn 2023 25 (9) 655-664 |
| TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase.
Pratt VM , Cavallari LH , Fulmer ML , Gaedigk A , Hachad H , Ji Y , Kalman LV , Ly RC , Moyer AM , Scott SA , van Schaik RHN , Whirl-Carrillo M , Weck KE . J Mol Diagn 2022 24 (10) 1051-1063 |
| Characterization of Reference Materials for TPMT and NUDT15 - A GeT-RM Collaborative Project.
Pratt VM , Wang WY , Boone EC , Broeckel U , Cody N , Edleman L , Gaedigk A , Lynnes TC , Medeiros E , Moyer AM , Mitchell MM , Scott SA , Starostik P , Turner A , Kalman LV . J Mol Diagn 2022 24 (10) 1079-1088 |
| CYP2C8, CYP2C9 and CYP2C19 characterization using Next Generation Sequencing and Haplotype Analysis: A GeT-RM Collaborative Project.
Gaedigk A , Boone EC , Scherer SE , Lee SB , Numanagi I , Sahinalp C , Smith JD , McGee S , Radhakrishnan A , Qin X , Wang WY , Farrow EG , Gonzaludo N , Halpern AL , Nickerson DA , Miller NA , Pratt VM , Kalman LV . J Mol Diagn 2022 24 (4) 337-350 |
| Characterization of Reference Materials for CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, GGCX, and Other Pharmacogenetic Alleles with an Association for Molecular Pathology (AMP) Pharmacogenetics Working Group Tier 2 Status - A GeT-RM Collaborative Project.
Pratt VM , Turner A , Broeckel U , Dawson DB , Gaedigk A , Lynnes TC , Medeiros EB , Moyer AM , Requesens D , Ventrini F , Kalman LV . J Mol Diagn 2021 23 (8) 952-958 |
| Characterization of 108 Genomic DNA Reference Materials for 11 Human Leukocyte Antigen (HLA) Loci: A GeT-RM Collaborative Project.
Bettinotti MP , Ferriola D , Duke JL , Mosbruger TL , Tairis N , Jennings L , Kalman LV , Monos D . J Mol Diagn 2018 20 (5) 703-715 
|
| Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology.
Pratt VM , Del Tredici AL , Hachad H , Ji Y , Kalman LV , Scott SA , Weck KE . J Mol Diagn 2018 20 (3) 269-276 |
| Development and Characterization of Reference Materials for Genetic Testing: Focus on Public Partnerships.
Kalman LV , Datta V , Williams M , Zook JM , Salit ML , Han JY . Ann Lab Med 2016 36 (6) 513-20 |
| Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
Pratt VM , Everts RE , Aggarwal P , Beyer BN , Broeckel U , Epstein-Baak R , Hujsak P , Kornreich R , Liao J , Lorier R , Scott SA , Smith CH , Toji LH , Turner A , Kalman LV . J Mol Diagn 2015 18 (1) 109-23 |
| Pharmacogenetic Allele Nomenclature: International Workgroup Recommendations for Test Result Reporting.
Kalman LV , Agundez JA , Appell ML , Black JL , Bell GC , Boukouvala S , Bruckner C , Bruford E , Caudle K , Coulthard SA , Daly AK , Del Tredici A , den Dunnen JT , Drozda K , Everts RE , Flockhart D , Freimuth RR , Gaedigk A , Hachad H , Hartshorne T , Ingelman-Sundberg M , Klein TE , Lauschke VM , Maglott DR , McLeod HL , McMillin GA , Meyer UA , Müller DJ , Nickerson DA , Oetting WS , Pacanowski M , Pratt VM , Relling MV , Roberts A , Rubinstein WS , Sangkuhl K , Schwab M , Scott SA , Sim SC , Thirumaran RK , Toji LH , Tyndale RF , van Schaik R , Whirl-Carrillo M , Yeo K , Zanger UM . Clin Pharmacol Ther 2015 99 (2) 172-85 |
| Development of a genomic DNA reference material panel for Rett syndrome (MECP2-related disorders) genetic testing.
Kalman LV , Tarleton JC , Percy AK , Aradhya S , Bale S , Barker SD , Bayrak-Toydemir P , Bridges C , Buller-Burckle AM , Das S , Iyer RK , Vo TD , Zvereff VV , Toji LH . J Mol Diagn 2014 16 (2) 273-9 |
| Current landscape and new paradigms of proficiency testing and external quality assessment for molecular genetics.
Kalman LV , Lubin IM , Barker S , du Sart D , Elles R , Grody WW , Pazzagli M , Richards S , Schrijver I , Zehnbauer B . Arch Pathol Lab Med 2013 137 (7) 983-988 |
| Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing
Barker SD , Bale S , Booker J , Buller A , Das S , Friedman K , Godwin AK , Grody WW , Highsmith E , Kant JA , Lyon E , Mao R , Monaghan KG , Payne DA , Pratt VM , Schrijver I , Shrimpton AE , Spector E , Telatar M , Toji L , Weck K , Zehnbauer B , Kalman LV . J Mol Diagn 2009 11 (6) 553-61 |
- Page last reviewed:Feb 1, 2024
- Content source: